The Kenyan government has recalled a Universal Corporation Limited-manufactured HIV medication.
The discolouration of the Tenofovir-Lamivudine-Dolutegravir (TDL) 300/300/50 mg tablets was the reason given by the Ministry of Health for the decision to recall the HIV medication.
The Ministry of Health and Human Services said in a statement that continuing quality analysis and consideration of its consequences for the customers’ safety are currently ongoing.
According to Patrick Amoth, acting director general for the Kenyan Department of Health, there are sufficient national supplies of HIV tablets from other manufacturers.
Copyright: News Central TV
All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from News Central TV.